KRISTI BARR: Open Payments
NPI 1528021268 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,800 in 190 payments from 15 companies in 2025. Trend: 2023 $4,101 · 2024 $4,026 · 2025 $2,800
Food & beverage: $2,800
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $452 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 40 | $329 |
| Collegium Pharmaceutical, Inc. | 21 | $305 |
| Supernus Pharmaceuticals, Inc. | 15 | $241 |
| ABBVIE INC. | 19 | $227 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $200 |
| Neurocrine BioSciences, Inc. | 12 | $188 |
| Janssen Pharmaceuticals, Inc | 10 | $182 |
| Alkermes, Inc. | 8 | $177 |
| Lundbeck LLC | 12 | $169 |
Products named: REXULTI, CAPLYTA, Jornay PM, VRAYLAR, Qelbree, TRINTELLIX, ABILIFY MAINTENA, INGREZZA.
Industry payments across PA — which companies pay providers there.
